2017_SBRT_Course Book

CONCLUSIONS • Initial results are promising in terms of o Biochemical response / control o GI Toxicity • Increased rates of GU toxicity • Un-answered questions o Clinical patient selection factors : P-Vol, IPSS, … o OAR tolerance doses o Prophylactic / premedication: tamsulosin, steroids … o Role in intermediate and high risk patients o Toxicity and biochemical control with sufficient FU Ø Should be practiced within prospective protocols

Matthias Guckenberger - ESTRO SBRT Course 2017

07.09.17

/ 27

/